BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM SUBSET ANALYSES OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 AND EOS-2 TRIALS

Alfredo J. Lucendo  ¹     Christoph Schlag  ²     Alex Straumann  ³     Guillermo José Ortega  ⁴     Ancor Sanz-García  ⁴     Cecilio Santander Vaquero  ⁵     Constanza Ciriza De Los Ríos  ⁶     Jan Tack  ⁷     Ralph Mueller  ⁸     Roland Greinwald  ⁸     Stephen Attwood9  ^9    
1 Hospital General de Tomelloso, Tomelloso, Spain
² Klinikum rechts der Isar - TU München, München, Germany
³ Swiss EoE Research Network, Olten, Switzerland
⁴ Hospital Universitario de La Princesa, Madrid, Spain
⁵ Hospital Universitario de la Princesa, Madrid, Spain
⁶ Hospital 12 de Octubre, Madrid, Spain
⁷ University Hospital Leuven, Leuven, Belgium
⁸ Dr. Falk Pharma GmbH, Freiburg, Germany
⁹ Durham University, North Tyneside, United Kingdom

Topic
Immunology, Oesophagus, Paediatrics

Session
Eosinophilic oesophagitis: The essential

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)